Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

redcare pharmacy nv - SAEYY

SAEYY

Close Chg Chg %
4.32 -0.32 -7.41%

Pre-Market

4.00

-0.32 (7.41%)

Volume: 1.25K

Last Updated:

Mar 23, 2026, 3:58 PM EDT

Trade Now

Company Overview: redcare pharmacy nv - SAEYY

SAEYY Key Data

Open

$3.59

 Day Range

3.59 - 4.00

52 Week Range

3.59 - 15.67

 Market Cap

$929.15M

Shares Outstanding

201.12M

 Public Float

N/A

Beta

1.71

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.21

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

624.00

  

SAEYY Performance

1 Week
 
 0.00%
 
1 Month
 
 -42.86%
 
3 Months
 
 -48.52%
 
1 Year
 
 -74.55%
 
5 Years
 
 N/A
 

SAEYY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Redcare Pharmacy Nv - SAEYY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.27B 1.94B 2.56B 3.32B
Sales Growth
+0.99% +53.64% +31.86% +29.44%
Cost of Goods Sold (COGS) incl D&A
958.57M 1.53B 2.05B 2.65B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
41.53M 61.93M 73.79M 78.32M
Depreciation
14.54M 17.33M 19.55M 20.99M
Amortization of Intangibles
26.99M 44.60M 54.24M 57.33M
COGS Growth
-1.19% +59.66% +33.79% +29.37%
Gross Income
307.17M 414.17M 516.57M 670.04M
Gross Income Growth
+8.46% +34.83% +24.73% +29.71%
Gross Profit Margin
+24.27% +21.30% +20.15% +20.19%
2022 2023 2024 2025 5-year trend
SG&A Expense
364.83M 432.27M 559.12M 695.43M
Research & Development
- - - -
-
Other SG&A
364.83M 432.27M 559.12M 695.43M
SGA Growth
+9.06% +18.48% +29.35% +24.38%
Other Operating Expense
- - - 1.47M
-
Unusual Expense
- 16.71M (12.95M) (338.57K)
EBIT after Unusual Expense
(74.37M) (5.15M) (42.55M) (26.52M)
Non Operating Income/Expense
641.09K 6.11M (928.09K) (4.85M)
Non-Operating Interest Income
- - - 4.97M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
15.03M 16.72M 8.72M 22.91M
Interest Expense Growth
-3.06% +11.20% -47.86% +162.84%
Gross Interest Expense
15.03M 16.72M 8.72M 22.91M
Interest Capitalized
- - - -
-
Pretax Income
(88.76M) (15.76M) (52.19M) (54.28M)
Pretax Income Growth
+3.05% +82.25% -231.23% -4.01%
Pretax Margin
-7.01% -0.81% -2.04% -1.64%
Income Tax
(6.80M) (2.96M) (1.60M) (9.37M)
Income Tax - Current - Domestic
(55.70K) 1.06M 699.85K 1.02M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(6.75M) (4.02M) (2.30M) (10.38M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(81.60M) (12.55M) (50.14M) (44.47M)
Minority Interest Expense
- 470.29K (964.87K) (1.92M)
Net Income
(81.60M) (13.02M) (49.18M) (42.55M)
Net Income Growth
+6.94% +84.05% -277.78% +13.48%
Net Margin Growth
-6.45% -0.67% -1.92% -1.28%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(81.60M) (13.02M) (49.18M) (42.55M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(81.60M) (13.02M) (49.18M) (42.55M)
EPS (Basic)
-0.4537 -0.0677 -0.2452 -0.2116
EPS (Basic) Growth
+7.46% +85.08% -262.19% +13.70%
Basic Shares Outstanding
179.85M 192.39M 200.54M 201.09M
EPS (Diluted)
-0.4537 -0.0677 -0.2452 -0.2116
EPS (Diluted) Growth
+7.46% +85.08% -262.19% +13.70%
Diluted Shares Outstanding
179.85M 192.39M 200.54M 201.09M
EBITDA
(16.13M) 43.84M 31.24M 51.46M
EBITDA Growth
+17.21% +371.73% -28.73% +64.71%
EBITDA Margin
-1.27% +2.25% +1.22% +1.55%

Redcare Pharmacy Nv in the News